Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery
Medical Marijuana Program Connection
MARCH 14, 2023
–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule. CAMBRIDGE, Mass.–(BUSINESS Read More
Let's personalize your content